JEDEDIAH MECHE: Open Payments
NPI 1598115057 · CROWLEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 10 payments from 8 companies in 2025. Trend: 2023 $971 · 2024 $633 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 1 | $58 |
| Amgen Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $13 |
Products named: Assure WCD, REPATHA, VERQUVO, LEQVIO, ZEPBOUND, Kerendia, Ozempic, LifeVest.
Industry payments across LA — which companies pay providers there.
